Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Oncology
|
January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
Nikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Cancers
|
February 10, 2021
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with <i>RAS</i> Wild Type Metastatic Colorectal Cancer
Said A Khelwatty, Soozana Puvanenthiran, Sharadah Essapen, et al.
Folia Parasitologica
|
September 11, 2004
Haemogregarina bigemina (Protozoa: Apicomplexa: Adeleorina)--past, present and future
Angela J Davies, Nico J Smit, Polly M Hayes, et al.
Oncotarget
|
March 23, 2019
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, et al.
Cancers
|
September 13, 2025
Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions
Said A Khelwatty, Soozana Puvanenthiran, Alan M Seddon, et al.
Folia Parasitologica
|
January 27, 2007
A new fish haemogregarine from South Africa and its suspected dual transmission with trypanosomes by a marine leech
Polly M Hayes, Nico J Smit, Alan M Seddon, et al.
Parasites & Vectors
|
November 24, 2011
Three-dimensional visualisation of developmental stages of an apicomplexan fish blood parasite in its invertebrate host
Polly M Hayes, David F Wertheim, Nico J Smit, et al.
Oncology Reports
|
October 25, 2024
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
Ozlem Sherif, Said A Khelwatty, Izhar Bagwan, et al.
Oncology Reports
|
October 30, 2020
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
Tanzeel Khan, Alan M Seddon, Angus G Dalgleish, et al.
Free Radical Biology & Medicine
|
May 27, 2005
Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes
Eirini Meimaridou, Jake Jacobson, Alan M Seddon, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Oncology
|
January 20, 2016
Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition
Nikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.
Cancers
|
February 10, 2021
HER2 Expression Is Predictive of Survival in Cetuximab Treated Patients with <i>RAS</i> Wild Type Metastatic Colorectal Cancer
Said A Khelwatty, Soozana Puvanenthiran, Sharadah Essapen, et al.
Folia Parasitologica
|
September 11, 2004
Haemogregarina bigemina (Protozoa: Apicomplexa: Adeleorina)--past, present and future
Angela J Davies, Nico J Smit, Polly M Hayes, et al.
Oncotarget
|
March 23, 2019
Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer
Said Abdullah Khelwatty, Sharadah Essapen, Izhar Bagwan, et al.
Cancers
|
September 13, 2025
Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions
Said A Khelwatty, Soozana Puvanenthiran, Alan M Seddon, et al.
Folia Parasitologica
|
January 27, 2007
A new fish haemogregarine from South Africa and its suspected dual transmission with trypanosomes by a marine leech
Polly M Hayes, Nico J Smit, Alan M Seddon, et al.
Parasites & Vectors
|
November 24, 2011
Three-dimensional visualisation of developmental stages of an apicomplexan fish blood parasite in its invertebrate host
Polly M Hayes, David F Wertheim, Nico J Smit, et al.
Oncology Reports
|
October 25, 2024
Expression of EGFRvIII and its co‑expression with wild‑type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma
Ozlem Sherif, Said A Khelwatty, Izhar Bagwan, et al.
Oncology Reports
|
October 30, 2020
Synergistic activity of agents targeting growth factor receptors, CDKs and downstream signaling molecules in a panel of pancreatic cancer cell lines and the identification of antagonistic combinations: Implications for future clinical trials in pancreatic cancer
Tanzeel Khan, Alan M Seddon, Angus G Dalgleish, et al.
Free Radical Biology & Medicine
|
May 27, 2005
Crystal and microparticle effects on MDCK cell superoxide production: oxalate-specific mitochondrial membrane potential changes
Eirini Meimaridou, Jake Jacobson, Alan M Seddon, et al.
Page
of 3